SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
MXN
  • USD
  • MXN
  • ARS
  • EUR
Mitarbeiter 25.200

Amgen Inc. outperformed den DAX um +92 % vom 04.06.2014 bis 19.02.2018

197 News & Informationen zur Amgen Inc. Aktie

  • U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.65% By Investing.com
    investing.com

    U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.65% By Investing.com

    U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.65%

  • Seizert Capital Partners, Llc Buys AutoZone Inc, Discovery Inc, Apple Inc, Sells Biogen Inc, Western Digital Corp, Acuity Brands Inc
    gurufocus.com

    Seizert Capital Partners, Llc Buys AutoZone Inc, Discovery Inc, Apple Inc, Sells Biogen Inc, Western Digital Corp, Acuity Brands Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Legato Capital Management LLC Buys iShares MSCI EAFE ETF, CVS Health Corp, Goldman Sachs Group Inc, Sells Bryn Mawr Bank Corp, HDFC Bank,...
    gurufocus.com

    Legato Capital Management LLC Buys iShares MSCI EAFE ETF, CVS Health Corp, Goldman Sachs Group Inc, Sells Bryn Mawr Bank Corp, HDFC Bank, Gilead Sciences Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026
    markets.businessinsider.com

    Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026

    SAN FRANCISCO, Aug. 20, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research comp…

  • Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026
    prnewswire.com

    Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026

    /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…

  • BeiGene : and EUSA Pharma Announce China NMPA Approval of QARZIBA® (Dinutuximab Beta) for Patients with High-Risk Neuroblastoma (Form 8-K)
    marketscreener.com

    BeiGene : and EUSA Pharma Announce China NMPA Approval of QARZIBA® (Dinutuximab Beta) for Patients with High-Risk Neuroblastoma (Form 8-K)

    BeiGene and EUSA Pharma Announce China NMPA Approval of QARZIBA® for Patients with High-Risk Neuroblastoma

    CAMBRIDGE, Mass., BEIJING, China, and HEMEL… | August 19, 2021

  • Biotech Small Caps Will Bounce Back
    etfdb.com

    Biotech Small Caps Will Bounce Back

    Large cap biotechnology have strengthened in recent months, but smaller counterparts are still waiting on their 2021 moment.

  • Colony Group Llc Buys SPDR MSCI USA StrategicFactors SM ETF, Vanguard FTSE Emerging Markets ETF, iShares MSCI USA Multifactor ETF, Sells...
    gurufocus.com

    Colony Group Llc Buys SPDR MSCI USA StrategicFactors SM ETF, Vanguard FTSE Emerging Markets ETF, iShares MSCI USA Multifactor ETF, Sells Brookfield Infrastructure Corp, BTC iShares MSCI USA Min Vol Fa

    GuruFocus Article or News written by insider and the topic is about:

  • Peloton Wealth Strategists Buys iShares iBonds Dec 2025 Term Corporate ETF, iShares iBonds Dec 2024 Term Corporate ETF, iShares iBonds Dec...
    gurufocus.com

    Peloton Wealth Strategists Buys iShares iBonds Dec 2025 Term Corporate ETF, iShares iBonds Dec 2024 Term Corporate ETF, iShares iBonds Dec 2026 Term Corporate ETF, Sells Royal Caribbean Group, Alphabe

    GuruFocus Article or News written by insider and the topic is about:

  • Regent Peak Wealth Advisors LLC Buys Accenture PLC, Oracle Corp, Taiwan Semiconductor Manufacturing Co, Sells iShares Gold Trust, Texas...
    gurufocus.com

    Regent Peak Wealth Advisors LLC Buys Accenture PLC, Oracle Corp, Taiwan Semiconductor Manufacturing Co, Sells iShares Gold Trust, Texas Instruments Inc, Amgen Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Global Regenerative Medicine Markets, 2021-2029: Focus On Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule & Biologics
    thestreet.com

    Global Regenerative Medicine Markets, 2021-2029: Focus On Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule & Biologics

    DUBLIN, Aug. 18, 2021 /PRNewswire/ — The

  • Global Regenerative Medicine Markets, 2021-2029: Focus on Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule & Biologics
    prnewswire.com

    Global Regenerative Medicine Markets, 2021-2029: Focus on Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule & Biologics

    /PRNewswire/ — The

  • Amgen Stock: Strong Pipeline Makes It A Buy (NASDAQ:AMGN)
    seekingalpha.com

    Amgen Stock: Strong Pipeline Makes It A Buy (NASDAQ:AMGN)

    Amgen continues to grow through large M&A, bolt-on M&A, and its own research. Here’s why I view AMGN stock as a long-term buy.

  • Cholesterol Lowering Drugs Market Report 2021-2028| Size, Share, Growth, Trends, Revenue, Competitive Analysis, Forecast
    globenewswire.com

    Cholesterol Lowering Drugs Market Report 2021-2028| Size, Share, Growth, Trends, Revenue, Competitive Analysis, Forecast

    Top Players Covered in the Cholesterol Lowering Drugs Market Research Report Are AstraZeneca, Pfizer Inc., Novartis AG, AbbVie Inc., Sun Pharmaceuticals…

  • Amgen Stock Is Undervalued By At Least 20% (NASDAQ:AMGN)
    seekingalpha.com

    Amgen Stock Is Undervalued By At Least 20% (NASDAQ:AMGN)

    Amgen reported solid second quarter results. I consider AMGN is at least 20% undervalued now. See why I think Amgen stock deserves a closer look at this point.

  • 2 Dow Stocks to Buy Hand Over Fist This Month
    entrepreneur.com

    2 Dow Stocks to Buy Hand Over Fist This Month

    The Dow Jones Industrial Average (DJIA) notched a fresh record close yesterday, despite fears surrounding the resurgence of COVID-19 cases and geopoli…

  • CytomX Therapeutics Announces New Employment Inducement Grants
    thestreet.com

    CytomX Therapeutics Announces New Employment Inducement Grants

    SOUTH SAN FRANCISCO, Calif., Aug. 17, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage, oncology-focused biopharmaceutical

  • All 30 Dow stocks are falling, led by Home Depot after earnings
    marketwatch.com

    All 30 Dow stocks are falling, led by Home Depot after earnings

    All 30 of the Dow Jones Industrial Average's undefined components are losing ground in premarket trading, as the Dow is on track of snapping a five-day win…

  • Day One Appoints Scott Garland to Board of Directors
    globenewswire.com

    Day One Appoints Scott Garland to Board of Directors

    SOUTH SAN FRANCISCO, Calif., Aug. 17, 2021 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company…

  • U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.31% By Investing.com
    investing.com

    U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.31% By Investing.com

    U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.31%

  • Ligand Pharmaceuticals Incorporated : Partner Travere Therapeutics Announces Positive Topline Interim Results from the Ongoing Phase 3...
    marketscreener.com

    Ligand Pharmaceuticals Incorporated : Partner Travere Therapeutics Announces Positive Topline Interim Results from the Ongoing Phase 3 PROTECT Study of Sparsentan in IgA Nephropathy

    Sparsentan treatment demonstrated a statistically significant mean reduction of proteinuria from baseline after 36 weeks, more than threefold the reduction of active comparator irbesartan… | August 16, 2021

  • Top Analyst Reports for Walmart, UnitedHealth & Starbucks
    zacks.com

    Top Analyst Reports for Walmart, UnitedHealth & Starbucks

    Today's Research Daily features new research reports on 16 major stocks, including Walmart Inc. (WMT), UnitedHealth Group Incorporated (UNH), and Starbucks Corporation (SBUX).

  • Amgen: Consider AMGN Stock For Your Dividend Growth Portfolio (NASDAQ:AMGN)
    seekingalpha.com

    Amgen: Consider AMGN Stock For Your Dividend Growth Portfolio (NASDAQ:AMGN)

    Amgen has decent growth prospects and is attractively valued. Read more to see why I think AMGN stock is a decent addition to a dividend growth portfolio.

  • Disney, tech stocks lift Dow, S&P 500 to record highs
    financialpost.com

    Disney, tech stocks lift Dow, S&P 500 to record highs

    The Dow and the S&P 500 hit record highs on Friday and were set for a second week of gains, as Walt Disney and tech-related shares rose, with the market…

  • Christian Lindner-Portfolio: 3 ETFs sind (k)eine gute Anlageidee?
    etf-yogi.de

    Christian Lindner-Portfolio: 3 ETFs sind (k)eine gute Anlageidee?

    Was taugt das Christian Lindner-Portfolio mit 3 ETFs aus dem ARD Sommerinterview. Im aktuellen Artikel habe ich es unter die Lupe genommen.

  • Global Cancer Vaccines Research Report 2021-2026: Leading Players are Merck & Co., GlaxoSmithKline and Dendreon
    prnewswire.com

    Global Cancer Vaccines Research Report 2021-2026: Leading Players are Merck & Co., GlaxoSmithKline and Dendreon

    /PRNewswire/ — The

  • Alpha Healthcare and Humacyte Announce Nominees for Election to Post-Merger Public Company Board of Directors
    globenewswire.com

    Alpha Healthcare and Humacyte Announce Nominees for Election to Post-Merger Public Company Board of Directors

    Nominees bring depth and diversity of scientific, commercial and financial experience to Board NEW YORK and DURHAM, N.C., Aug. 13, 2021 (GLOBE NEWSWIRE)…

  • U.S. Severe Oral Mucositis Market to Surpass US$ 267.7 Million by 2028, Says Coherent Market Insights (CMI)
    globenewswire.com

    U.S. Severe Oral Mucositis Market to Surpass US$ 267.7 Million by 2028, Says Coherent Market Insights (CMI)

    SEATTLE, Aug. 12, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the U.S. Severe Oral Mucositis Market is estimated to be valued at US$…

  • Regenerative Medicine Market Size Worth $57.08 Billion By 2027: Grand View Research, Inc.
    markets.businessinsider.com

    Regenerative Medicine Market Size Worth $57.08 Billion By 2027: Grand View Research, Inc.

    SAN FRANCISCO, Aug. 12, 2021 /PRNewswire/ — The global regenerative medicine market size is expected to reach USD 57.08 billion by 2027, growing …

  • XOMA Announces Heather L. Franklin Joins its Board of Directors
    globenewswire.com

    XOMA Announces Heather L. Franklin Joins its Board of Directors

    EMERYVILLE, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) — XOMA Corporation (NASDAQ: XOMA) announced today Heather L. Franklin, President and Chief Executive…

  • What is the Dow Jones Industrial Average?
    investmentu.com

    What is the Dow Jones Industrial Average?

    The Dow Jones Industrial Average tracks the 30 largest public companies in the United States. These companies set the bar for the market.

  • Moderna’s stock price is ‘ridiculous,’ says BofA analyst
    marketwatch.com

    Moderna’s stock price is ‘ridiculous,’ says BofA analyst

    Shares of Moderna Inc. have climbed so much that the biotechnology company's valuation is 'unjustifiable on a fundamental basis,' said analyst Geoff Meacham,…

  • 4 Top Healthcare Stocks on the Dow Jones Index By StockNews
    investing.com

  • 4 Top Healthcare Stocks on the Dow Jones Index
    entrepreneur.com

    4 Top Healthcare Stocks on the Dow Jones Index

    The Dow Jones Industrial Average closed at a record high last week, with stocks tied to economic recovery gaining significantly after a strong jobs re…

  • Moderna's Stock Valuation Goes From 'Unreasonable To Ridiculous': Analyst
    markets.businessinsider.com

    Moderna's Stock Valuation Goes From 'Unreasonable To Ridiculous': Analyst

    Moderna, Inc. (NASDAQ:MRNA) shares have rallied since the start of July, rendering the valuation unattractive and

  • Were Hedge Funds Right About Union Pacific Corporation (UNP)?
    insidermonkey.com

    Were Hedge Funds Right About Union Pacific Corporation (UNP)?

    The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.

  • Panbela Announces Issuance of key U.S. Patent; Patent is for Claims of a Novel Process for the Production of SBP-101
    asiaone.com

    Panbela Announces Issuance of key U.S. Patent; Patent is for Claims of a Novel Process for the Production of SBP-101

    Panbela Announces Issuance of key U.S. Patent; Patent is for Claims of a Novel Process for the Production of SBP-101
    Patent developed in collaboration with Syngene International Ltd

    GlobeNewswire

    August 09, 2021

    MINNEAPOLIS, Aug. 09, 2021 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for…

  • 3 more House reps have broken the law by failing to properly disclose their financial trades
    markets.businessinsider.com

    3 more House reps have broken the law by failing to properly disclose their financial trades

    Reps. Steve Chabot, a Republican from Ohio; Cheri Bustos, a Democrat from Illinois; and August Pfluger, a Republican from Texas. Tom Williams/CQ…

  • U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.41% By Investing.com
    investing.com

    U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.41% By Investing.com

    U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.41%

  • Disney And Salesforce Gain As The DIA Finishes Higher Thursday
    benzinga.com

    Disney And Salesforce Gain As The DIA Finishes Higher Thursday

    U.S. indices finished higher Thursday as traders and investors contemplate recent earnings and weigh ongoing COVID-19 Delta variant guidance. The SPDR Dow …

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Dir gefallen die Informationen zu Amgen Inc.?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Amgen Inc.?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Amgen Inc.?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Amgen Inc.?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba